Pfizer Q1 revenues jump 77% to $25.7 bn on Covid-19 vaccine

Pfizer reported another quarter of huge revenues growth because of its COVID-19 vaccine on Tuesday, but lowered the company’s full-year profit forecast due in part to shifts in foreign exchange.

This article was originally published on this website.